Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Electroporation-device

 Transdermal thermal polymerization
The present invention, in one aspect, is a method for polymerizing or crosslinking by transdermal ...


 Method for identifying an oligonucleotide aptamer specific for a target
We claim: 1. A method for identifying an aptamer which specifically binds to thrombin, wherein the ...


 Plant transcription regulators from circovirus
OF THE INVENTION The present invention is further described by reference to the following non-...


 Methods for modulation of the effects of aging on the primate brain
The invention provides a clinically useful protocol for delivery of recombinant nervous system ...


 Genetic engineering of cells to enhance healing and tissue regeneration
OF THE INVENTION It has been discovered that cells can be genetically engineered to produce ...


 Vascular endothelial growth factor-D (VEGF-D) polypeptides
OF THE INVENTION The invention will now be described in detail by reference to the figures, and to ...


 Methods for treating viral infection using IL-28 and IL-29
We claim: 1. A method of treating a viral infection comprising administering to an ...


 Method of manufacturing an electrohydraulic probe
OF THE INVENTION Referring to FIG. 1 there is shown a diagrammatical view of the bladder 2, ureter ...


 Releasable linkage and compositions containing same
Accordingly, it is an object of the invention to provide a compound where a ligand is covalently ...


 Solid phase dispersion of quinolone or naphthyridonecarboxylic acids
What is claimed is: 1. A solid phase dispersion comprising a micronized quinolinecarboxylic acid or ...


 Electroporation device

Details
Inventors: Firth, Kevin L.;
Assignee:
Primary Examiner: Warden; Robert J.
Assistant Examiner: Trembley; T. A.
Attorney, Agent or Firm:

An electroporation apparatus provides for the electroporation of cells attached to an electrode. The electrode may be transparent to allow cell viewing. If the electrode exhibits a voltage drop a constant electrical field may be obtained over the cell layer by controlling the position or character of the opposed electrode. Alternately, cells may be electroporated under an electrical field which varies in a continuous, geometrically uniform manner over the cell layer.

DETAILED DESCRIPTION I claim: 1.
An electroporation apparatus for electroporating living cells with molecules comprising: (a) first and second electrodes, respectively having, first and second mutually opposed electrode surfaces, said first and second mutually opposed electrode surfaces being positioned to create an electric field there-between when connected to a source of electrical potential, said first electrode being only partially conductive and exhibiting a voltage drop across its said first electrode surface upon the passage of current therethrough; (b) an electrolyte positioned between said first and second said electrolyte containing molecules to be deposited within living cells by electroporation and being in contact with said first and second electrode surfaces; (c) living cells attached to said first electrode surface and being in contact with said electrolyte, and (d) containment means positioned to contain the electrolyte and living cells between said first and second electrodes, wherein by reason of the spacing between opposed portions of said first and second mutually opposed electrode surfaces, said second electrode, in combination with said first electrode, provides a local electrical field over said first electrode surface which is of substantially equal strength over said first electrode surface.
2.
An apparatus as in claim 1 wherein said first and second mutually opposed electrode surfaces are planar.
3.
An apparatus as in claim 2, wherein said second electrode surface is angled with respect to said first electrode surface to create along said first electrode surface said local electrical field of substantially equal strength.
4.
An apparatus as in claim 1, 2 or 3 wherein; (a) said first electrode comprises a non-conductive substrate; (b) said first electrode surface comprises a partially conductive layer bonded to said non-conductive substrate, and (c) said non-conductive substrate and partially conductive layer are sufficiently transparent or translucent to allow viewing of the living cells on said first electrode surface under a microscope by transmitted light



Related patents
  Implantable electroporation method and apparatus for drug and gene delivery
Accordingly, it is the primary object of the present invention to provide an improved method of electroporation mediated, in vivo, intracellular drug and gene delivery ...
  Flow electroporation chamber with electrodes having a crystalline metal nitride coating
The present invention provides improved electrodes for use in generating an electrical field in a saline solution. In particular, the invention relates to continuous ...
  Solely pollen-specific promoter
What is claimed is: 1. An isolated solely pollen-specific promoter derived from Arabidopsis comprising a complete nucleotide sequence of SEQ ID NO: 1 derived from the A...
  Gene transfer using transformed, neodetermined, embryonic cells
This invention relates to the preparation of carrier cells capable of delivering genetic material to a particular tissue of the body by means of embryonic cells ...
  Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
The present invention provides methods and compositions for inhibiting loss of bone mass, and/or for stimulating bone formation in mammals, particularly humans. In one ...
  Imidazole-containing cationic amphiphiles for intracellular delivery of therapeutic molecules
The present invention provides for cationic amphiphiles that are particularly effective to facilitate transport of biologically active molecules into cells. R...
  Cationic amphiphiles containing multiplesteroid lipophilic groups
The present invention provides for cationic amphiphiles that are particularly effective to facilitate transport of biologically active molecules into cells. R...
  N-terminally chemically modified protein compositions and methods
What is claimed is: 1. A preparation comprising a predominant amount of a monopolymer/protein conjugate prepared from a hematopoietic protein having one or more ...
  Membrane virus host range mutations and their uses as vaccine substrates
What is claimed is: 1. A genetically engineered Arbovirus comprising, a transmembrane glycoprotein with a deletion of one or more amino acids in a transmembrane domain ...
  Aminoethylation process for production of substituted ethylene diamines
What is claimed is: 1. A process for preparing a 1,2-ethanediamine in a ring opening reaction of an oxazolidinone, the process comprising contacting an oxazolidinone ...

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved